Pomalyst approved for advanced multiple myeloma
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Feb 9, 2013
0
0
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Feb 9, 2013
0
0
Autism Speaks, the world's leading autism science and advocacy organization, is proud to announce the release of biological and clinical data from 383 new families participating in Autism Speaks Autism Genetic Resource Exchange ...
Nov 8, 2012
0
0
A University of Birmingham fetal medicine expert has helped to shape new advice from NICE on antenatal care for women pregnant with twins or triplets. Professor Mark Kilby says the new guideline, published today (September ...
Sep 28, 2011
0
0
With 3,284 cycles using frozen eggs, Italy is the leader in Europe, the 27th Annual Meeting of the European Society of Human Reproduction and Embryology heard Wednesday.
Jul 6, 2011
0
0
Australian researchers have made the significant discovery that loss of a twin during very early pregnancy explains the increased risk of birth defects seen in multiple pregnancies after infertility treatment.
Jul 5, 2011
0
0
Imagine babies so tiny a wedding ring can fit around their arms. Often weighing less than a pound, these remarkably small and sick infants hold onto life hooked up to a maze of tubes and beeping monitors. Although no parent ...
Apr 26, 2011
0
0
The number of couples struggling with infertility is on the rise, and these couples often use assisted reproductive technologies, like in vitro fertilization (IVF), to get pregnant. Although IVF can be successful, it can ...
Apr 14, 2011
0
0